Xerosyn
K-Number: K233259 · 2024-06-21
ApplicantXerothera, Inc.
Decision Date2024-06-21
Product CodeMQV
Advisory CommitteeOR
DecisionSubstantially Equivalent
Device Summary
Xerosyn is a medical device manufactured by Xerothera, Inc.. It received FDA 510(k) clearance on 2024-06-21 under approval number K233259. The device is classified under product code MQV. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Xerosyn?
Xerosyn is a medical device that received FDA 510(k) clearance on 2024-06-21. It is manufactured by Xerothera, Inc.. The 510(k) number is K233259.
When was Xerosyn approved by the FDA?
Xerosyn received FDA 510(k) clearance on 2024-06-21, under approval number K233259.
What company makes Xerosyn?
Xerosyn is manufactured by Xerothera, Inc..
What is the FDA product code for Xerosyn?
The FDA product code for Xerosyn is MQV.
Related Devices (Code: MQV)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.